AstraZeneca: all 4,196 studies
Page 21 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With ItraconazoleCompletedNCT05551897Phase 1
- Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major BleedCompletedNCT05548777
- Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRmActive, not recruitingNCT05546866Phase 2
- A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)Active, not recruitingNCT05526755Phase 2
- Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy SubjectsCompletedNCT05526690Phase 1
- Pharmacokinetics of Cotadutide in Participants With Hepatic ImpairmentTerminatedNCT05517226Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursActive, not recruitingNCT05514132Phase 1
- A Bioavailability and Food Effect Study of AZD5462 in Healthy VolunteersCompletedNCT05512806Phase 1
- Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or ObeseCompletedNCT05511025Phase 1
- Long-term Follow-up Study of Patients Who Received hLB-001 Gene TherapyActive, not recruitingNCT05506254
- Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.CompletedNCT05505162Phase 1
- Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy ParticipantsActive, not recruitingNCT05501717Phase 1
- Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy SubjectsCompletedNCT05500820Phase 1
- Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal FunctionCompletedNCT05470725Phase 1
- An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid MalignanciesCompletedNCT05469919Phase 1
- Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)CompletedNCT05465213
- Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal InsufficiencyCompletedNCT05462119
- A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.CompletedNCT05457270Phase 1
- A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in RussiaActive, not recruitingNCT05456867
- AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's DiseaseCompletedNCT05452304Phase 1
- A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based ChemotherapyActive, not recruitingNCT05450692Phase 3
- A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.CompletedNCT05440656
- Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female VolunteersCompletedNCT05438303Phase 1
- Chinese Multiple Dose Escalation (MDE) High Dose StudyCompletedNCT05437848Phase 1
- A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese AdultsCompletedNCT05437289Phase 1
- National Acalabrutinib Observational StudyActive, not recruitingNCT05437250
- PORTHOS - PORTuguese Heart Failure Observational StudyCompletedNCT05434923
- Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy ParticipantsCompletedNCT05428696Phase 1
- A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)CompletedNCT05419401Phase 1
- Tracking Treatment Pathways in Adult Patients With Hyperkalemia.CompletedNCT05408039
- A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and DigoxinCompletedNCT05395117Phase 1
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNHActive, not recruitingNCT05389449Phase 3
- PASS of Paediatric Patients Initiating SelumetinibActive, not recruitingNCT05388370
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy SubjectsCompletedNCT05384262Phase 1
- Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCActive, not recruitingNCT05374603Phase 2
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)Active, not recruitingNCT05374512Phase 3
- Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate CancerActive, not recruitingNCT05367440Phase 1/2
- A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833CompletedNCT05364255Phase 1
- A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursTerminatedNCT05363605Phase 1/2
- A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African AncestryCompletedNCT05351047Phase 1
- Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT05348577Phase 3
- Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDActive, not recruitingNCT05346354Phase 2/3
- Himalaya Early Access ProgramApproved for marketingNCT05345678
- Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in AnifrolumabCompletedNCT05339100Phase 1
- Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council CountriesCompletedNCT05315323
- Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With ProteinuriaCompletedNCT05314231Phase 1
- REported Outcomes in COPD With Trixeo in Real worlD in GermanyCompletedNCT05311306
- Forxiga CKD Japan Post-Marketing Surveillance (PMS)CompletedNCT05306210
- Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCActive, not recruitingNCT05301842Phase 3
- An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart FailureCompletedNCT05297409
- A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy SubjectsCompletedNCT05294458Phase 1
- LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE StudyCompletedNCT05282017
- Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal HemoglobinuriaCompletedNCT05274633
- Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)CompletedNCT05271526
- A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in ChinaCompletedNCT05271266
- Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.CompletedNCT05267613Phase 3
- Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single ComponentsCompletedNCT05266404Phase 1
- Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentActive, not recruitingNCT05261399Phase 3
- Study of ALXN2050 in Participants With Hepatic ImpairmentTerminatedNCT05259085Phase 1
- Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 VaccinesCompletedNCT05252442
- Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaCompletedNCT05251259Phase 2
- Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical PracticeCompletedNCT05250011
- OREIOS International StudyCompletedNCT05239507
- A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With ItraconazoleCompletedNCT05236543Phase 1
- Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in EnglandCompletedNCT05222750
- A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT05221840Phase 3
- Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)CompletedNCT05219630
- Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).Active, not recruitingNCT05219500Phase 2
- REported Outcomes in COPD With Trixeo in Real worlDCompletedNCT05213611
- A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCActive, not recruitingNCT05211895Phase 3
- Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer PatientsCompletedNCT05203458
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedNCT05202145Phase 1
- Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.CompletedNCT05188144
- Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium LevelsCompletedNCT05184998
- Zoladex® 10.8 BC RWSCompletedNCT05184257
- A Study on Disease Awareness and Treatment Compliance of Heart Failure PatientsCompletedNCT05180396
- Multicenter Prospective Observational Study Evaluating the Management of Heart FailureCompletedNCT05180370
- RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.CompletedNCT05180357
- Prevalence and Characterisation of Asthma Patients According to Disease Severity in PortugalCompletedNCT05169619
- Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsCompletedNCT05166889Phase 3
- QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing SurveillanceCompletedNCT05160974
- Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.CompletedNCT05158387Phase 3
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy ParticipantsCompletedNCT05143905Phase 1
- SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)Active, not recruitingNCT05141201
- CLL Therapy Approaches in RussiaActive, not recruitingNCT05140369
- A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult ParticipantsCompletedNCT05140096Phase 1
- Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisActive, not recruitingNCT05138133Phase 3
- Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim DatabaseCompletedNCT05136547
- VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIACompletedNCT05135455
- Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsCompletedNCT05134727Phase 1
- Dapagliflozin Post Marketing Surveillance in HF and CKDCompletedNCT05134701
- EU Secondary Data Post-Authorisation Safety Study of AZD1222CompletedNCT05126992
- A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour ResectionActive, not recruitingNCT05120349Phase 3
- A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal ImpairmentCompletedNCT05112419Phase 1
- A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonistsCompletedNCT05110976Phase 1
- Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in ChinaCompletedNCT05110261Phase 3
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy AdultsCompletedNCT05109390Phase 1
- Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy ParticipantsCompletedNCT05107336Phase 1
- Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR MutationsActive, not recruitingNCT05103605
- Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform NeurofibromasActive, not recruitingNCT05101148Phase 1